FDA Approves Fresh Round of COVID Vaccines… But Americans Simply Aren’t Interested
The FDA has approved a fresh round of COVID-19 vaccines from pharmaceutical giants Pfizer and Moderna, although less than a quarter of Americans are expected to take the jab.
Vaccines are expected to start shipping in the coming days. However, despite a resurgence of COVID-19 in some parts of the country, interest in taking the latest vaccine or “booster” is at a record low.
This lack of demand has led to a decline in the fortunes of both Pfizer and Moderna. Earlier this year, Moderna posted a $1.2 billion loss after sales of the COVID jab collapsed, having previously reaped billions in profits from the pandemic.
The New York Times explains:
The availability of boosters has not translated into actual vaccinations.
